GlaserB, ThorntonP, OtonkoskiT, JunienC.Genetics of hyperinsulinism. Arch Dis Child2000;82:F79–F86.
2.
GoossensA, GeptsW, SaudubrayJ-M, Diffuse and focal nesidioblastosis: a clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol1989;13:766–775.
3.
JaffeR, HashidaY, YunisEJ. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest1980;42:356–365.
4.
LeeMP, HuRJ, JohnsonLA, FeinbergAP. Human KV-LQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedmann syndrome chromosomal rearrangements. Nat Genet1997;15:181–185.
5.
DeBaunMR, NiemitzEL, McNeilDE, Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet2002;70:604–611.
6.
DemolombeS, FrancoD, de BoerP, Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am J Physiol Cell Physiol2001;280:C359–C372.
7.
LeeMP, RavenelJD, HuRJ, Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest2000;106:1467–1479.
8.
MunnsCF, BatchJA. Hyperinsulinism and Beckwith-Wiedemann syndrome. Arch Dis Child2001;84:F67–F69.
9.
StefanY, BordiC, GrassoS, OrciL.Beckwith-Wiedemann syndrome: a quantitative, immunohistochemical study of pancreatic islet cell populations. Diabetologia1985;28:914–919.
10.
FukuzawaR, UmezawaA, MorikawaY, Nesidioblastosis and mixed hamartoma of the liver in Beckwith-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting. Pediatr Dev Pathol2001;4:381–390.
